Max Bronstein's guest appearances

Max Bronstein

Two Disabled Dudes - Living with Urgency

The Delphi Podcast

POV Crypto Podcast: Your Crypto Echo-Chamber Dies Here.

Raise the Line

Mark Cuban

Kyle Samani

Dan Zuller

Mike Alfred

Alex Mashinsky

Zaki Manian

Dean Tribble

Matthew Finlayson

Rune Christensen

Jeff Dorman

Nathaniel Whittemore

Aleks Larsen

Trevor Koverko

Ryan Zurrer

John McAfee

OwlTail

The growth in skepticism about science that was fueled by disinformation during the pandemic has been a frequent topic on Raise the Line, with many insightful guests from medicine and academia offering analysis of the problem and possible solutions. On today’s episode, we’ll hear from someone who is very well-placed to actually make progress on this front. Max Bronstein, the Assistant Director for Health Innovation at the White House Office of Science and Technology Policy, joins host Shiv Gaglani to discuss the broad support President Biden has provided for science – elevating his science advisor to the cabinet level being a prime example – and also provide details about programmatic investments that tell the tale at a deeper level. At the top of Bronstein’s list of examples is the launch of the Advanced Research Projects Agency for Health, also known as ARPA-H, which aims to drive transformative biomedical and health breakthroughs with a focus on equity. “The mission is about making sure there are cures for diseases, better diagnostic platforms and better technologies out there, but also making sure those are actually available to all Americans.” Don’t miss this inside look at new efforts to strengthen the biotechnology workforce, broaden access to clinical genetic sequencing, advance development of treatments for rare diseases, and much more as a new era in health innovation gets underway.  Mentioned in this episode: https://www.whitehouse.gov/ostp/

The growth in skepticism about science that was fueled by disinformation during the pandemic has been a frequent topic on Raise the Line, with many insightful guests from medicine and academia offering analysis of the problem and possible solutions. On today’s episode, we’ll hear from someone who is very well-placed to actually make progress on this front. Max Bronstein, the Assistant Director for Health Innovation at the White House Office of Science and Technology Policy, joins host Shiv Gaglani to discuss the broad support President Biden has provided for science – elevating his science advisor to the cabinet level being a prime example – and also provide details about programmatic investments that tell the tale at a deeper level. At the top of Bronstein’s list of examples is the launch of the Advanced Research Projects Agency for Health, also known as ARPA-H, which aims to drive transformative biomedical and health breakthroughs with a focus on equity. “The mission is about making sure there are cures for diseases, better diagnostic platforms and better technologies out there, but also making sure those are actually available to all Americans.” Don’t miss this inside look at new efforts to strengthen the biotechnology workforce, broaden access to clinical genetic sequencing, advance development of treatments for rare diseases, and much more as a new era in health innovation gets underway.  Mentioned in this episode: <a href="https://www.whitehouse.gov/ostp/" rel="nofollow" target="_blank">https://www.whitehouse.gov/ostp/</a>

Fostering Respect for Science and Support for Health Innovation - Max Bronstein, Assistant Director of the White House Office of Science and Technology Policy

Host Tom Shaughnessy of Delphi Digital (www.DelphiDigital.io) is joined by Max Bronstein of the Dharma Protocol. Dharma enables users to instantly borrow and lend crypto-assets in high volume. This is a two-part DeFi series, stay tuned for part 2 next week.    Follow Tom on Twitter @Shaughnessy119 Follow Max on Twitter @max_bronstein     Disclosure: Tom Shaughnessy owns tokens in ETH, DCR, MKR, ZRX and HYDRO. This podcast is NOT investment advice and is only informational. Do not make investment decisions based upon this podcast. Delphi Digital was not compensated by any party for this podcast episode other than Podbean's advertisers. This content is strictly informational.  - Advertisers: To advertise on this podcast, email Tom@DelphiDigital.io Potential Guests: If you're interested in appearing on the podcast, email Tom@DelphiDigital.io  - 

Host Tom Shaughnessy of Delphi Digital <a href="https://51pct.io/" rel="nofollow" target="_blank">(</a><a href="http://www.DelphiDigital.io" rel="nofollow" target="_blank">www.DelphiDigital.io</a>) is joined by Max Bronstein of the Dharma Protocol. Dharma enables users to instantly borrow and lend crypto-assets in high volume. This is a two-part DeFi series, stay tuned for part 2 next week.  <ul><li>Follow Tom on Twitter <a href="https://twitter.com/Shaughnessy119" rel="nofollow" target="_blank">@Shaughnessy119</a></li> <li>Follow Max on Twitter <a href="https://twitter.com/max_bronstein" rel="nofollow" target="_blank">@max_bronstein </a></li> </ul> Disclosure: Tom Shaughnessy owns tokens in ETH, DCR, MKR, ZRX and HYDRO. This podcast is NOT investment advice and is only informational. Do not make investment decisions based upon this podcast. Delphi Digital was not compensated by any party for this podcast episode other than Podbean's advertisers. This content is strictly informational.  - Advertisers: To advertise on this podcast, email Tom@DelphiDigital.io Potential Guests: If you're interested in appearing on the podcast, email Tom@DelphiDigital.io  -

Max Bronstein from Dharma: #DeFi and The Importance of Debt Markets In Crypto

"We have a big innovation gap in this country when it comes to rare disease therapies. 7,000 diseases and only roughly 300 treatments on the market for those diseases. We have a long way to go and there's a lot of work that needs to be done if we ever want to get to the point where we have one treatment for all of those diseases or even multiple treatments - and that is what our foundation is set up and designed to do."For our second interview before Rare Disease Day (Feb 28), we chat with Max Bronstein, Chief Advocacy and Science Policy Officer at The Everylife Foundation for Rare Diseases. The goal of the Foundation is to help advance innovation in the rare disease community; to advance knowledge and methods of support for those with a rare disease, and to ultimately look towards developing and enabling access to treatments or cures.Max is a scientist at heart; he has been published in Nature and The New England Journal of Medicine which makes him a great ally in raising awareness of rare diseases. He uses his background in his job at The Everylife Foundation in two big ways.One way that he uses his science background is what he calls regulatory issues. He does this by continuously holding meetings with large health and biotech and pharma partners. He speaks directly to the doctors and scientists at the forefront of cutting edge research in health and medicine and reminds them of the reality of rare diseases, a field often overlooked or forgotten.Another way that Max is a voice for those in the rare disease community is by working in social policy issues. This is when Max sets up meetings with politicians so that the rare disease community is represented. This involves dialoguing with senators and representatives on Capitol Hill whenever drug costs, talks of healthcare, or any other issue related to the rare disease community arises, and also just to meet with them regularly to remind them of the reality of rare diseases. He regularly goes to both the White House and Congress.Max explains these to us and walks us through a big success that The Everylife Foundation and other organizations helped push through instituted: the 21st Century Cures Act.Keep in touch with The Everylife Foundation to keep up with all of their diverse efforts and  find out how you can get involved! Visit their website at http://everylifefoundation.org, and follow them on Facebook: https://www.facebook.com/EveryLife4RareDiseases/, and Twitter: @EveryLifeOrg.

"We have a big innovation gap in this country when it comes to rare disease therapies. 7,000 diseases and only roughly 300 treatments on the market for those diseases. We have a long way to go and there's a lot of work that needs to be done if we ever want to get to the point where we have one treatment for all of those diseases or even multiple treatments - and that is what our foundation is set up and designed to do." For our second interview before Rare Disease Day (Feb 28), we chat with Max Bronstein, Chief Advocacy and Science Policy Officer at The Everylife Foundation for Rare Diseases. The goal of the Foundation is to help advance innovation in the rare disease community; to advance knowledge and methods of support for those with a rare disease, and to ultimately look towards developing and enabling access to treatments or cures. Max is a scientist at heart; he has been published in Nature and The New England Journal of Medicine which makes him a great ally in raising awareness of rare diseases. He uses his background in his job at The Everylife Foundation in two big ways. One way that he uses his science background is what he calls regulatory issues. He does this by continuously holding meetings with large health and biotech and pharma partners. He speaks directly to the doctors and scientists at the forefront of cutting edge research in health and medicine and reminds them of the reality of rare diseases, a field often overlooked or forgotten. Another way that Max is a voice for those in the rare disease community is by working in social policy issues. This is when Max sets up meetings with politicians so that the rare disease community is represented. This involves dialoguing with senators and representatives on Capitol Hill whenever drug costs, talks of healthcare, or any other issue related to the rare disease community arises, and also just to meet with them regularly to remind them of the reality of rare diseases. He regularly goes to both the White House and Congress. Max explains these to us and walks us through a big success that The Everylife Foundation and other organizations helped push through instituted: the 21st Century Cures Act. Keep in touch with The Everylife Foundation to keep up with all of their diverse efforts and  find out how you can get involved! Visit their website at <a href="http://everylifefoundation.org" rel="nofollow" target="_blank">http://everylifefoundation.org</a>, and follow them on Facebook: <a href="https://www.facebook.com/EveryLife4RareDiseases/" rel="nofollow" target="_blank">https://www.facebook.com/EveryLife4RareDiseases/</a>, and Twitter: @EveryLifeOrg.

007 – Interview with Max Bronstein of the EveryLife Foundation